Cargando…
Macrophage polarization synergizes with oxaliplatin in lung cancer immunotherapy via enhanced tumor cell phagocytosis
Calreticulin (CALR) exposure is required for most immunogenic cell death (ICD) in the anti-tumor immunity induced by chemotherapeutic agents. The present study aimed to explore the anti-tumor efficacy of the combined administration of oxaliplatin (OXA) and R848 (an agent for macrophage polarization)...
Autores principales: | Li, Fei, Zheng, Xue, Wang, Xue, Xu, Jinhua, Zhang, Qianyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365514/ https://www.ncbi.nlm.nih.gov/pubmed/34390893 http://dx.doi.org/10.1016/j.tranon.2021.101202 |
Ejemplares similares
-
Targeting tumor-associated macrophages to synergize tumor immunotherapy
por: Xiang, Xiaonan, et al.
Publicado: (2021) -
Oxaliplatin and infliximab synergize to induce regression of colon cancer
por: Huang, Di, et al.
Publicado: (2018) -
A hybrid bacterium with tumor-associated macrophage polarization for enhanced photothermal-immunotherapy
por: Zhao, Jingya, et al.
Publicado: (2022) -
Oxaliplatin facilitates tumor-infiltration of T cells and natural-killer cells for enhanced tumor immunotherapy in lung cancer model
por: Xin, Min, et al.
Publicado: (2021) -
Specific function and modulation of teleost monocytes/macrophages: polarization and phagocytosis
por: Lu, Xin-Jiang, et al.
Publicado: (2019)